Yang J, Wang W, Lu Y, Li C, Wei S, Sun W
BMC Endocr Disord. 2025; 25(1):26.
PMID: 39885490
PMC: 11780996.
DOI: 10.1186/s12902-025-01857-9.
Avram C, Mederle A, Mavrea A, Barata P, Patrascu R
Life (Basel). 2025; 15(1.
PMID: 39859954
PMC: 11767224.
DOI: 10.3390/life15010014.
Yang S, Huang Y, Lou X, Lyu T, Wei R, Mehta H
JCO Clin Cancer Inform. 2025; 9():e2400139.
PMID: 39818952
PMC: 11748906.
DOI: 10.1200/CCI.24.00139.
Hwang J, You S, Lee Y, Sun J
Eur Radiol. 2024; 35(1):276-288.
PMID: 39026064
DOI: 10.1007/s00330-024-10952-9.
Wei W, Wang Y, Ouyang R, Wang T, Chen R, Yuan X
Ann Surg Oncol. 2024; 31(12):7738-7749.
PMID: 39014163
DOI: 10.1245/s10434-024-15762-3.
Lung cancer in the emergency department.
Walder J, Faiz S, Sandoval M
Emerg Cancer Care. 2024; 2(1):3.
PMID: 38799792
PMC: 11116267.
DOI: 10.1186/s44201-023-00018-9.
Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening.
Cartmel B, Fucito L, Bold K, Neveu S, Li F, Rojewski A
J Thorac Oncol. 2023; 19(4):643-649.
PMID: 37977486
PMC: 10999350.
DOI: 10.1016/j.jtho.2023.11.012.
Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening: A Sequential, Multiple Assignment, Randomized Trial.
Fu S, Rothman A, Vock D, Lindgren B, Almirall D, Begnaud A
JAMA Netw Open. 2023; 6(8):e2329903.
PMID: 37615989
PMC: 10450571.
DOI: 10.1001/jamanetworkopen.2023.29903.
Serum and Bronchoalveolar Lavage Fluid Levels of Cytokines in Patients with Lung Cancer and Chronic Lung Disease: A Prospective Comparative Study.
Hogea P, Tudorache E, Fira-Mladinescu O, Marc M, Velescu D, Manolescu D
J Pers Med. 2023; 13(6).
PMID: 37373987
PMC: 10303634.
DOI: 10.3390/jpm13060998.
Influenza season influence on outcome of new nodules in the NELSON study.
Lancaster H, Heuvelmans M, de Bock G, Du Y, Mohamed Hoesein F, Nackaerts K
Sci Rep. 2023; 13(1):6589.
PMID: 37085595
PMC: 10121576.
DOI: 10.1038/s41598-023-33672-4.
A narrative review of lung cancer screening in underserved populations.
Toubat O, David E
Curr Chall Thorac Surg. 2023; 5.
PMID: 37064329
PMC: 10103952.
DOI: 10.21037/ccts-20-173.
Lung Cancer Screening Knowledge in Four Internal Medicine Programs.
Urrutia Argueta S, Basnet N, Abdul-Kafi O, Hanna N
Cancer Control. 2023; 29:10732748221081383.
PMID: 36895164
PMC: 10009012.
DOI: 10.1177/10732748221081383.
Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
Patel A, Miller E, Regis S, Hunninghake G, Price L, Gawlik M
Respir Res. 2023; 24(1):49.
PMID: 36782326
PMC: 9926562.
DOI: 10.1186/s12931-023-02359-9.
How Timely Is Diagnosis of Lung Cancer? Cohort Study of Individuals with Lung Cancer Presenting in Ambulatory Care in the United States.
Zigman Suchsland M, Kowalski L, Burkhardt H, Prado M, Kessler L, Yetisgen M
Cancers (Basel). 2022; 14(23).
PMID: 36497238
PMC: 9740627.
DOI: 10.3390/cancers14235756.
Procedural complications associated with invasive diagnostic procedures after lung cancer screening with low-dose computed tomography.
Yang S, Shih Y, Huo J, Mehta H, Wu Y, Salloum R
Lung Cancer. 2022; 165:141-144.
PMID: 35124410
PMC: 9250944.
DOI: 10.1016/j.lungcan.2021.12.020.
Prospects for cost-effective lung cancer screening using risk calculators.
Weber M, McWilliams A, Canfell K
Transl Cancer Res. 2022; 8(Suppl 2):S141-S144.
PMID: 35117085
PMC: 8799126.
DOI: 10.21037/tcr.2018.12.08.
Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.
Burks E, Zhang J, Sullivan T, Shi X, Sands J, Regis S
Cancer Treat Res Commun. 2021; 29:100486.
PMID: 34794107
PMC: 8713084.
DOI: 10.1016/j.ctarc.2021.100486.
Cancer nanotechnology: current status and perspectives.
Kemp J, Kwon Y
Nano Converg. 2021; 8(1):34.
PMID: 34727233
PMC: 8560887.
DOI: 10.1186/s40580-021-00282-7.
Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort.
Gazourian L, Regis S, Pagura E, Price L, Gawlik M, Lamb C
Respir Med. 2021; 186:106540.
PMID: 34311389
PMC: 8579718.
DOI: 10.1016/j.rmed.2021.106540.
Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model.
Sun C, Zhang X, Guo S, Liu Y, Zhou L, Shi J
BMJ Open. 2021; 11(7):e046742.
PMID: 34210726
PMC: 8252866.
DOI: 10.1136/bmjopen-2020-046742.